Regulatory Spine Top Stories SpinaFX Medical receives FDA Investigational Device Exemption (IDE) for Triojection®, its Breakthrough, Minimally-Invasive, Image-Guided Lumbar Disc Treatment. byJosh SandbergJune 9, 2026
Spine Top Stories Centinel Spine® Completes Enrollment in First-of-its-Kind 2-Level IDE Trial Evaluating prodisc® C Match-the-Disc™ Cervical TDR System byJosh SandbergJune 13, 2023
Recon Top Stories Hip Innovation Technology Announces Initiation of FDA Approved Investigational Device Exemption Study byJosh SandbergJanuary 12, 2023
Biologics Top Stories Cerapedics Completes Enrollment of Pivotal U.S. FDA IDE Study for its P-15L Bone Graft byChris StewartFebruary 24, 2022
Recon Regulatory Top Stories FX Solutions, SAS. [FX Shoulder, Inc.] Completes Easytech Reversed® Stemless IDE Enrollment in the USA byJosh SandbergJanuary 27, 2022
Recon Regulatory Hip Innovation Technology Receives FDA Investigational Device Exemption (IDE) Approval to Initiate Landmark Study of its Reverse Hip Replacement System byJosh SandbergJanuary 19, 2022
Spine NuVasive Simplify Cervical Disc Data Published In International Journal Of Spine Surgery byChris StewartSeptember 9, 2021
Extremities Recon LimaCorporate Announces First Successful Operation with SMR Stemless Reverse Shoulder Systems in IDE Study byChris StewartApril 20, 2021
Recon Regulatory LimaCorporate Announces FDA Approval for an Ide Study on Smr Stemless Reverse Shoulder System byJosh SandbergNovember 19, 2020
Extremities Hospitals Anika Therapeutics Files Investigational Device Exemption to Initiate Phase III Study to Expand Indication of MONOVISC® to Treat Pain Caused by Osteoarthritis of the Hip byJosh SandbergJune 23, 2015
